MAIT cells in metabolic diseases - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Molecular metabolism Year : 2018

MAIT cells in metabolic diseases

Léo Bertrand
Agnès Lehuen
  • Function : Correspondent author
  • PersonId : 968677
  • IdHAL : agnes-lehuen

Connectez-vous pour contacter l'auteur


Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial and fungal vitamin B metabolites. MAIT cells can promote inflammation and are present in many organs central to metabolism, suggesting a role in the etiopathology of these diseases. SCOPE OF THE REVIEW: Here, we will review what is known of the involvement of MAIT cells in metabolic pathologies in humans and mice. MAJOR CONCLUSIONS: MAIT cells are severely affected, overactivated with a frequency reduction and a phenotype shift from protective to deleterious. Therefore, they might be a novel target to treat, in particular, pancreas and liver metabolic diseases.
Fichier principal
Vignette du fichier
1-s2.0-S2212877819304168-main.pdf (1.69 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-02339506 , version 1 (30-10-2019)



Léo Bertrand, Agnès Lehuen. MAIT cells in metabolic diseases. Molecular metabolism, 2018, 27S, pp.S114-S121. ⟨10.1016/j.molmet.2019.06.025⟩. ⟨inserm-02339506⟩
94 View
81 Download



Gmail Facebook Twitter LinkedIn More